Definitive Healthcare (DH) Stock Price, News & Analysis

Company Overview

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities. Users can access real-time insights into referral patterns, procedure volumes, affiliation networks and payer mix, as well as news alerts and forecasting tools. Definitive Healthcare also provides specialized modules for emerging therapeutic areas, such as oncology and medical device utilization, as well as workflow integrations with customer relationship management (CRM) and business intelligence (BI) systems.

Founded in 2011 by Brian Atwood, Definitive Healthcare has grown organically and through strategic acquisitions to broaden its content, geographies and analytical capabilities. The company completed its initial public offering in July 2021, marking a milestone in its expansion journey. It maintains headquarters in Nashville, Tennessee, and operates additional offices in North America and Europe to support a global customer base.

Leadership at Definitive Healthcare is anchored by founder and Chief Executive Officer Brian Atwood, who oversees the company’s product strategy, data operations and go-to-market initiatives. Under his direction, the management team has focused on fostering a data-driven culture, forging partnerships with key industry stakeholders and investing in advanced analytics to address the evolving needs of healthcare and life sciences organizations worldwide.

Key Stats

• Today's Range: $0.61 to $0.64
• 50-Day Range: $0.63 to $0.90
• 52-Week Range: $0.61 to $4.35
• Volume: 221,920 shs
• Average Volume: 356,351 shs
• Market Capitalization: $67.68 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.47
• Consensus Rating: Reduce

Definitive Healthcare Stock Analysis - MarketRank™

Definitive Healthcare scored higher than 56% of companies evaluated by MarketBeat, and ranked 457th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Reduce

Consensus Rating

Definitive Healthcare has received a consensus rating of Reduce. The company's average rating score is 1.89, and is based on 1 strong buy rating, no buy ratings, 5 hold ratings, and 3 sell ratings.

Upside Potential

Definitive Healthcare has a consensus price target of $1.47, representing about 132.1% upside from its current price of $0.63.

Amount of Analyst Coverage

Definitive Healthcare has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -25.00%

Earnings Growth

Earnings for Definitive Healthcare are expected to decrease by -25.00% in the coming year, from $0.04 to $0.03 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Definitive Healthcare is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Definitive Healthcare is -0.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Definitive Healthcare has a PEG Ratio of 10.49. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Definitive Healthcare has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

2.25% of the float of Definitive Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Definitive Healthcare has a short interest ratio ("days to cover") of 12.05, which indicates bearish sentiment.

Change versus previous month

Short interest in Definitive Healthcare has recently decreased by 3.65%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Definitive Healthcare does not currently pay a dividend.

Dividend Growth

Definitive Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.58

News Sentiment

Definitive Healthcare has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Definitive Healthcare this week, compared to 2 articles on an average week.

MarketBeat Follows

1 people have added Definitive Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Definitive Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.09% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 8/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:DH
• CIK: 1861795
• Web: www.definitivehc.com
• Phone: 508-720-4224
• Fax: N/A
• Employees: 970
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Definitive Healthcare: $1.47
• High Price Target: $3.00
• Low Price Target: $0.70
• Potential Upside/Downside: +132.8%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.89
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.60)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 15.80
• P/E Growth: 10.49
• Net Income: -$138.93 million
• Net Margins: -72.28%
• Pretax Margin: -106.74%
• Return on Equity: 3.18%
• Return on Assets: 1.52%

Debt

• Debt-to-Equity Ratio: 0.81
• Current Ratio: 1.75
• Quick Ratio: 1.75

Sales & Book Value

• Annual Sales: $241.52 million
• Price / Sales: 0.28
• Cash Flow: $1.92 per share
• Price / Cash Flow: 0.33
• Book Value: $2.66 per share
• Price / Book: 0.24

Miscellaneous

• Outstanding Shares: 106,750,000
• Free Float: 87,490,000
• Market Cap: $67.47 million
• Optionable: Not Optionable
• Beta: 1.35